Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC Rimonabant hydrochloride 158681-13-1 1g
SDP

Catalog No. 5000096898
Encompass_Preferred

Rimonabant hydrochloride (CAS 158681-13-1) is a small-molecule inverse agonist targeting the cannabinoid receptor subtype CB1 It is designed to modulate endocannabinoid signaling pathways thereby regulating processes related to appetite control lipid metabolism and energy homeostasis Rimonabant hydrochloride exerts its biological activity primarily through selective inverse agonism at CB1 receptors It demonstrates high receptor binding affinity with a Ki value of approximately 1 8 nM Based on these pharmacological properties Rimonabant hydrochloride holds research potential in cannabinoid receptor pharmacology metabolic regulation and obesity-associated disorders

Catalog No. 50-000-96898 Supplier Apexbio Technology LLC Supplier No. A37661000
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Rimonabant hydrochloride (CAS 158681-13-1) is a small-molecule inverse agonist targeting the cannabinoid receptor subtype CB1 It is designed to modulate endocannabinoid signaling pathways thereby regulating processes related to appetite control lipid metabolism and energy homeostasis Rimonabant hydrochloride exerts its biological activity primarily through selective inverse agonism at CB1 receptors It demonstrates high receptor binding affinity with a Ki value of approximately 1 8 nM Based on these pharmacological properties Rimonabant hydrochloride holds research potential in cannabinoid receptor pharmacology metabolic regulation and obesity-associated disorders

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.